Emergent BioSolutions Inc. - Common Stock (EBS)

CUSIP: 29089Q105

Q2 2024 13F Holders as of 30 Jun 2024

Type / Class
Equity / Common Stock
Shares outstanding
51,688,294
Total 13F shares
30,424,097
Share change
-5,414,981
Total reported value
$207,508,937
Put/Call ratio
515%
Price per share
$6.82
Number of holders
137
Value change
-$26,587,800
Number of buys
81
Number of sells
61

Security key

29089Q105

Report period

Q2 2024

Institutions

137

Top holders

10

Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
14%
7,060,208
$17,862,325 31 Mar 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
8%
4,151,319
$10,502,837 31 Mar 2024
13F
VANGUARD GROUP INC
13F
Company
6.6%
3,411,549
$8,631,220 31 Mar 2024
13F
Avidity Partners Management LP
13F
Company
3.7%
1,908,000
$4,827,240 31 Mar 2024
13F
MORGAN STANLEY
13F
Company
2.5%
1,293,702
$3,273,067 31 Mar 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
2.2%
1,121,195
$2,836,961 31 Mar 2024
13F
TWO SIGMA ADVISERS, LP
13F
Company
2.1%
1,073,800
$2,716,714 31 Mar 2024
13F
STATE STREET CORP
13F
Company
2%
1,057,593
$2,675,710 31 Mar 2024
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
2%
1,051,698
$2,602,952 31 Mar 2024
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
2%
1,013,570
$2,564,332 31 Mar 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.7%
894,158
$2,262,220 31 Mar 2024
13F
Invesco Ltd.
13F
Company
1.7%
892,879
$2,258,984 31 Mar 2024
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
1.7%
891,300
$2,255,000 31 Mar 2024
13F
Assenagon Asset Management S.A.
13F
Company
1.6%
839,414
$2,123,717 31 Mar 2024
13F
FULLER & THALER ASSET MANAGEMENT, INC.
13F
Company
1.5%
775,625
$1,962,331 31 Mar 2024
13F
Connor, Clark & Lunn Investment Management Ltd.
13F
Company
1.4%
706,235
$1,786,775 31 Mar 2024
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
1.1%
591,933
$1,497,590 31 Mar 2024
13F
Values First Advisors, Inc.
13F
Company
0.91%
470,087
$1,189,320 31 Mar 2024
13F
PALISADE CAPITAL MANAGEMENT, LP
13F
Company
0.89%
461,648
$1,167,969 31 Mar 2024
13F
NORTHERN TRUST CORP
13F
Company
0.87%
447,600
$1,132,428 31 Mar 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.81%
416,664
$1,054,160 31 Mar 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.77%
398,063
$1,007,099 31 Mar 2024
13F
DIMENSIONAL FUND ADVISORS LP
13F
Company
0.74%
382,244
$967,078 31 Mar 2024
13F
MARSHALL WACE, LLP
13F
Company
0.6%
309,472
$782,963 31 Mar 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.57%
292,953
$741,171 31 Mar 2024
13F
UBS Group AG
13F
Company
0.55%
286,039
$723,679 31 Mar 2024
13F
PRUDENTIAL FINANCIAL INC
13F
Company
0.55%
284,810
$720,569 31 Mar 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.53%
273,540
$692,056 31 Mar 2024
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
0.5%
258,692
$654,491 31 Mar 2024
13F
Hilltop Holdings Inc.
13F
Company
0.4%
206,699
$522,948 31 Mar 2024
13F
LOS ANGELES CAPITAL MANAGEMENT LLC
13F
Company
0.38%
193,991
$490,797 31 Mar 2024
13F
Cetera Investment Advisers
13F
Company
0.33%
170,951
$432,506 31 Mar 2024
13F
Bank of New York Mellon Corp
13F
Company
0.33%
170,029
$430,174 31 Mar 2024
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.32%
163,589
$413,880 31 Mar 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.31%
159,421
$403,335 31 Mar 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.3%
153,404
$388,112 31 Mar 2024
13F
ARISTEIA CAPITAL, L.L.C.
13F
Company
0.28%
144,788
$366,314 31 Mar 2024
13F
JANE STREET GROUP, LLC
13F
Company
0.24%
123,176
$311,635 31 Mar 2024
13F
SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC
13F
Company
0.23%
118,647
$300,177 31 Mar 2024
13F
TRUIST FINANCIAL CORP
13F
Company
0.23%
117,166
$296,430 31 Mar 2024
13F
SeaCrest Wealth Management, LLC
13F
Company
0.19%
96,000
$242,880 31 Mar 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.17%
87,544
$221,470 31 Mar 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.16%
83,070
$210,167 31 Mar 2024
13F
HSBC HOLDINGS PLC
13F
Company
0.12%
64,429
$163,005 31 Mar 2024
13F
SG Americas Securities, LLC
13F
Company
0.11%
58,721
$149,000 31 Mar 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.11%
56,201
$142,189 31 Mar 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.1%
54,000
$136,620 31 Mar 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.08%
41,388
$104,712 31 Mar 2024
13F
State of Wyoming
13F
Company
0.08%
40,796
$103,214 31 Mar 2024
13F
BARCLAYS PLC
13F
Company
0.07%
38,204
$96,656 31 Mar 2024
13F

Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2024

As of 30 Jun 2024, Emergent BioSolutions Inc. - Common Stock (EBS) was held by 137 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 30,424,097 shares. The largest 10 holders included BlackRock Inc., VANGUARD GROUP INC, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, MORGAN STANLEY, MILLENNIUM MANAGEMENT LLC, Invesco Ltd., AMERICAN CENTURY COMPANIES INC, Connor, Clark & Lunn Investment Management Ltd., D. E. Shaw & Co., Inc., and FULLER & THALER ASSET MANAGEMENT, INC.. This page lists 137 institutional shareholders reporting positions in this security for the Q2 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2024 vs Q1 2024 Across Filers

Q1 2024 holders
115
Q2 2024 holders
137
Holder diff
22
Investor Q1 2024 Shares Q2 2024 Shares Share Diff Share Chg % Q1 2024 Value $ Q2 2024 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .